Thymalfasin Research
Thymalfasin combined with immune checkpoint inhibitors in treatment of non-small cell lung cancer
Pak J Med Sci·March 1, 2026
Chinese research group
Summary
Study of thymalfasin (thymosin alpha-1) as immunoadjuvant combined with checkpoint inhibitors in NSCLC treatment.
Study Details
Study Design
Retrospective cohort study
Indication
Non-small cell lung cancer
Intervention
Thymalfasin combined with immune checkpoint inhibitors
Species
Human